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Abstract: The heat shock protein 70 (Hsp70) family of chaperones play crucial roles in protein folding and 
have been linked to numerous diseases. We were interested in developing a generally applicable assay format 
for the Hsp70 family and have developed fluorescence polarization based assays for both the mammalian 
Hsp72 and its bacterial counterpart, DnaK. These assays are comparable in assay set-up, incubation condi-
tions and buffer components. Both unfolded polypeptides and synthetic peptides can be utilized as tracers to 
detect binding although peptides meeting the minimum seven residue length for Hsp70 binders have weaken 
binding when modified with fluorescein presumably due to steric effects. Although we did not identify a suit-
able general substrate for all Hsp70 proteins, fluorescein tagged peptide substrates that gave high affinity 
binding were identified for both DnaK and hsp72. We would predict that these assays will be suitable for 
identifying both selective chemical probes of Hsp70 family members and “pan” Hsp70 inhibitors. 
INTRODUCTION 
  Heat shock protein 70 (Hsp70) chaperones are highly 
conserved both structurally and functionally among different 
species [1]. Family members including mammalian Hsp70 
and its bacterial ortholog DnaK, play important housekeep-
ing roles in the cell assisting in protein folding and traffick-
ing [2]. During stress conditions, Hsp70 proteins help pre-
vention of insoluble aggregates by transiently binding to 
exposed hydrophobic regions of denatured or misfolded pro-
teins. The mammalian Hsp70 family consist of multiple 
members [3] with the best characterized including a constitu-
tive form (hsc70/Hsp73) and a stress-inducible form 
(hsp70/Hsp72)
(i). A role for Hsp70 proteins in many thera-
peutic areas including autoimmunity, transplantation, viral 
infections, neurodegenerative diseases and cancer has been 
well documented [2, 4-6]. Induction of Hsp70 proteins in 
response to environmental stresses protects cells from apop-
tosis and such a mechanism is frequently observed in cancer 
cells [7]. The inducible Hsp72 is often constitutively ex-
pressed in cancer cells [8].  
  Hsp70 proteins consist of two domains, an ATP-binding 
domain and a polypeptide-binding domain [3]. Substrates 
bind with high affinity to the ADP-bound form of Hsp70 
proteins and conversion of ADP to ATP results in rapid sub-
strate release [9, 10]. Co-chaperones mediate the hydrolysis 
of ATP on Hsp70 converting it back to the high affinity 
ADP-bound state. Hsp70 proteins bind to short exposed hy-
drophobic stretches on substrate proteins. Hsp70 activity has 
been observed in vitro by incubating purified Hsp70 with 
unfolded substrates and measuring binding. Due to their   
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function in binding a wide range of protein sequences, defin-
ing the peptide specificities of Hsp70 chaperones has been 
challenging and synthetic peptide and/or phage display li-
braries have been used extensively to map the binding re-
quirements for various Hsp70 family members including 
DnaK [11-13], Hsc70 [14, 15] and Hsp70 [16, 17]. Linear 
peptides with a minimum peptide length of seven amino ac-
ids are required for binding [14, 17, 18]. The interaction of 
Hsp70 with their substrate peptides or unfolded polypeptides 
is a relatively weak interaction and for certain peptides Kd 
values in the submicromolar range have been reported [17, 
19, 20]. 
  Although bacterial DnaK and mammalian Hsp70 proteins 
show a high degree of homology (45-50% amino acid simi-
larity) and share the same overall structure [21], there are 
reported differences in their peptide binding selectivity’s 
towards different peptides sequences [17, 19-21]. DnaK has 
a preference for a peptide binding motif containing a hydro-
phobic core sequence of 4-5 residues flanked by basic resi-
dues [12]. Hsp72 has a preference for peptides enriched in 
aromatic and hydrophobic amino acids with less binding to 
charged resides [16]. Other reports suggest a preference for 
charged peptides containing Lys or Arg [22] and no hydro-
phobic residues. These differences may reflect close or over-
lapping binding pockets for substrate [22]. 
  Despite the interest in modulating Hsp70 activity there is 
a distinct lack of chemical probes or inhibitors. Hsc70 has 
been demonstrated to bind to certain immunosuppressive 
drugs such as 15-deoxyspergualin (DSG) [23] with moderate 
affinity (Kd = 0.5 M) although the binding site for DSG 
seems to be distinct from the peptide binding site [24]. Pep-
tides derived from HLA Class I heavy chain have also been 
shown to have immunosuppressive properties and to bind to 
Hsp70 proteins [25, 26]. Compounds targeting the ATP do-
main of Hsp70 such as 3’-sulfogalactolipids [27] have also 
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mum region of a Hsp70 substrate bound Hsp72 preferentially 
compared to Hsc70 [8]. For DnaK, some compounds binding 
to the substrate site display antibacterial activity [28]. Taken 
together these studies suggest differences in binding selectiv-
ity’s of Hsp70 family members and that a number of poten-
tial binding sites/pockets exist on Hsp70 proteins including; 
a hydrophobic substrate site, a charged substrate site, the 
ATPase site, a “DSG-site” and the co-chaperone binding site 
that could all potentially be modulated with chemical probes 
or inhibitors. 
  A number of approaches have been taken to measure 
Hsp70 activity and develop assays that could be utilized to 
identify chemical probes/inhibitors. We have previously de-
veloped polyacrylamide gel-based [29] and chroma-
tographic-based [20] assays to assess the binding of peptide 
substrates by Hsp70 family members. Typically these assays 
are qualitative in nature and not robust enough for high 
throughput screening. HTS-amenable assays based on modu-
lating the ATPase activity of DnaK [30] and fluorescence 
polarization (FP) assays for peptide binding to Hsp70 [31] 
have recently been reported.  
  In order to identify inhibitors with varying selectivity for 
Hsp70 family members we have taken a chemical genomics 
approach as has been taken for other target classes such as 
kinases [32] and begun to develop a panel of Hsp70 assays 
using an assay format based on fluorescence polarization and 
testing a range of potential substrates. 
(i) Hsp70 refers to all members of the Hsp70 family; Hsc70 is 
the constitutive from of mammalian Hsp70; Hsp72 is the 
mammalian inducible form of Hsp70. 
MATERIALS AND METHODS 
Materials 
  Recombinant human heat shock protein 72 was either 
expressed in E.coli and purified as described previously [29] 
or purchased from Sigma (H7283). DnaK was obtained from 
Stressgen (SPP-630). Labeled and unlabeled synthetic pep-
tides were synthesized using conventional Fmoc chemistry 
(Applied Biosystems Corp. and Anaspec Inc.). Prior to de-
protection the resin for each peptide was divided into two 
portions. One portion of the resin was deprotected and 
cleaved as normal. The remainder of the resin was reacted 
with carboxyfluorescein succinimidyl ester (Invitogen) using 
a 20-fold molar excess. Unreacted NHS-fluorescein was 
washed away and the labeled peptide deprotected and 
cleaved as normal. Masses of peptides were confirmed by 
mass spectrum and HPLC. A model unfolded polypeptide, 
reduced and carboxymethylated lactabumin (RCMLA; 
Sigma) was labeled in solution with NHS-fluorescein (Invi-
trogen) as described previously [29]. MALDI-TOF MS 
analysis of the fluorescein labeled RCMLA indicated that 
there were on average three fluorescein groups per RCMLA 
molecule (data not shown). 
Fluorescence Polarization Measurements 
  All assay and fluorescence polarization (FP) measure-
ments were performed at room temperature and with a 10 
min incubation. The assay buffer used consisted of 25 mM 
HEPES pH 7.2, 150 mM KCl. Binding was assessed by in-
cubating increasing concentrations of a Hsp70 protein with a 
fixed concentration of fluorescently-labeled substrate and FP 
values measured. FP measurements were performed either 
on a Beacon Fluorescence Polarization system (Invitrogen) 
or PHERAstar microreader (BMG Labtech) using the FP 
filter set (emission 450 and excitation 520 nm). FP values 
are expressed in millipolarization (mP) units. All statistical 
analyses were performed with GraphPad Prism 5.0 software. 
Binding data was analyzed using a non-linear regression 
analysis method (single site binding model) in Prizm 5.0. 
RESULTS AND DISCUSSION 
Substrates for Hsp70 Family Members DnaK and Hsp72 
  We are interested in developing assays for a range of 
Hsp70 protein family members. As the best characterized, 
we began with mammalian Hsp72 and bacterial DnaK. Fluo-
rescence polarization (FP) was chosen as the assay format as 
it has been generally applicable to measuring protein-protein 
or protein-ligand interactions [33] including other heat shock 
proteins [31, 34]. The advantages of FP include that it is a 
homogeneous format, utilizes small substrates and the assays 
are generally insensitive to fluorescence interference. 
Unfolded Polypeptide Substrate 
  To provide a valuable readout, the FP substrate should 
bind specifically and with high affinity to the target protein. 
Substrate binding was first assessed using the permanently 
unfolded model substrate, reduced and carboxymethylated 
lactalbumin (RCMLA). We have previously shown in a gel 
shift assay format that both DnaK and Hsp72 can bind to 
RCMLA [29]. RCMLA was fluorescently labeled with fluo-
rescein (Flu-RCMLA) and binding to Hsp72 and DnaK as-
sessed as described in materials and methods. The data for 











Fig. (1). Titration of Hsp72 with the model unfolded polypep-
tide RCMLA.  
Various concentrations of Hsp72 were incubated with (1.67 g/ml) 
fluorescein-labeled RCMLA (flu-RCMLA) for 10 min at room 
temperature and FP values measured.  
 
  The data in Fig. (1) yielded an apparent Kd value of 1.53 
M. A comparable value (apparent Kd value of 2.0 M) was 
obtained for DnaK (data not shown). Although Flu-RCMLA 
could potentially fulfill the requirement for a universal 
Hsp70 substrate, the relatively low affinity, limited assay 
window of ~ 20 mP and the challenge in consistently prepar-
ing the substrate precluded its use. For these reasons we de-92    Current Chemical Genomics, 2008, Volume 2  Ricci and Williams 
cided to look to small peptide substrates to facilitate Hsp70 
assays. 
Synthetic Peptide Substrates 
  Due to their function in binding a wide range of protein 
sequences, defining the peptide specificities of Hsp70 chap-
erones has been challenging. A number of groups have used 
synthetic peptides to map such motifs [12-14, 16-20, 22, 35]. 
For DnaK the bacterial form of Hsp70, a 21-mer peptide 
comprising the targeting sequence of the precursor of mito-
chondrial aspartate aminotransferase (ALLQSRLLLSAPR-
RAAATARA; peptide name ALLQ, Table 1) had been pre-
viously identified [11] as binding tightly. It was also shown 
[11] that this peptide could be fluorescently tagged on the N-
terminus and used to follow real time binding by monitoring 
changes in fluorescence upon peptide binding.  
  Because of the reported relatively high affinity of this 
peptide for DnaK (63 nM) [11] we first used this sequence 
(Table 1) as the basis for developing a fluorescence polariza-
tion assay for measuring peptide binding to DnaK and poten-
tially to other Hsp70 proteins. The ALLQ peptide was la-
beled with NHS-fluorescein on the N-terminus on resin (Flu-
ALLQ). Because labeling is done prior to deprotection only 
the N-terminal amine is labeled. This is especially advanta-
geous for labeling of lysine/arginine containing peptides.  
  A second peptide containing predominantly lysine and 
arginine residues (NIVRKKK; peptide name KKK) previ-
ously shown to bind Hsp70 proteins [17] was also labeled 
on-resin using NHS-fluorescein. Peptide substrates used in 
these studies are shown in Table 1. 
Table  1.  Peptide Sequences Used as Hsp70 Substrates   
Protein/Tracer Optimization 
Peptide Sequence  Peptide Name  Ref. 
ALLQSRLLLSAPRRAAATARA ALLQ  [11] 
NRLLLTG LLL  [35] 
NIVRKKK KKK  [17] 
RENLRIALRY HLA  [25] 
 
  The optimal trace concentration was determined for each 
fluorescent-peptide. Each peptide was titrated and the fluo-
rescence intensity measured. The ratio of fluorescence inten-
sity to background was plotted versus tracer concentration. 
For optimal sensitivity, the fluorescently labeled peptide 
tracer concentration was set to produce a total fluorescence 
signal-to-background ratio greater than 50. For example, for 
Flu-ALLQ this required a concentration of 50 nM (data not 
shown) and 10 nM for Flu-KKK (Fig. 2). 
Fluorescence Polarization Assays for DnaK and Hsp72 
DnaK FP Assay 
  Binding of DnaK to a fixed concentration of Flu-ALLQ 
(50 nM) was determined. For this experiment it was deter-
mined that an incubation time of 10 min at room temperature 
was sufficient to reach equilibrium. A binding isotherm con-
structed by plotting DnaK concentration against millipolari-
zation (mP) values shows that DnaK binds in a dose-
dependent manner. As the concentration of DnaK is in-
creased mP values increase until saturation is reached (Fig. 










Fig. (2). Tracer Optimization.  
The signal-to-background was calculated as the fluorescence inten-
sity in the presence of labeled Flu-KKK divided by the fluorescence 












Fig. (3). Binding Isotherms for Flu-ALLQ to DnaK. 
Increasing concentrations of DnaK were incubated with Flu-ALLQ 
at room temperature for 10 min and the FP values measured. Data 
were plotted in GraphPad Prizm 5.0. 
 
  The data in Fig. (3) was analyzed using a non-linear re-
gression analysis method (single site binding model) in 
Prizm 5.0 and yielded an apparent Kd value of 64.4 nM, very 
close to that reported previously [11]. A Scatchard plot trans-
formation of the same data (not shown) yielded a value of 
53.7 nM for “target concentration” (x intercept) indicating 
stoichiometric 1:1 binding of peptide substrate ligand and 
DnaK in this FP assay.  
  It has been shown that Hsp70 members associate with 
polypeptide substrates or peptides in the presence of ADP 
whereas the ATP bound form of Hsp70 proteins have poor 
affinity for substrates [10]. We tested the effect of ADP and 
ATP on the FP assay. The addition of ADP to the assay did 
not affect the binding of labeled substrates (data not shown) 
suggesting that the Hsp72 proteins as tested exist in a pre-
dominantly ADP-bound form as a result of their purification 
using ATP affinity chromatography [29]. For DnaK binding 
to Flu-ALLQ, no peptide binding was measurable in the 
presence of 3 mM ATP/1 mM MgCl2 (data not shown) sug-
gesting that this FP assay can detect conformational changes 
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Competition Binding Assay for DnaK  
  Using the information obtained in the binding isotherm 
experiments, we next developed a competition binding assay 
in which tracer and protein concentrations are fixed and in-
creasing concentrations of compounds are added and as-
sessed for inhibition. DnaK and Flu-ALLQ concentrations 
were fixed at 200 nM and 50 nM respectively to give ~90% 
binding. Compounds can then be added over a range of con-
centrations and mP values measured after incubation. 
  To further validate the competitive DnaK FP assay, the 
IC50 for a known DnaK binding peptide was to be deter-
mined. In the absence of any known DnaK binding small 
molecules, another peptide previously identified as a DnaK 
binder was assessed in this assay. The peptide with sequence 
NRLLLTG (Table 1; termed LLL) was previously identified 
as a DnaK binder from phage display screening [35] and has 
been well characterized as a DnaK binder [37-39]. The Kd 
for LLL mediated stimulation of DnaK ATPase was previ-
ously reported as 10 M [35]. LLL was analyzed in our FP 











Fig. (4). Competitive displacement assay for LLL binding to 
DnaK. 
Assays were performed in triplicate with 200 nM DnaK and 50 nM 
Flu-ALLQ. Various concentrations of the LLL peptide were added 
and FP values measured after 10 min. The average values and stan-
dard deviation are plotted and the curve was fitted in GraphPad 
Prizm 5.0. 
 
  The LLL peptide inhibited Flu-ALLQ binding to DnaK, 
with an IC50 value of 2.4 M comparable to that reported 
previously [35], and an R-squared value of 0.97 for curve fit. 
A preliminary analysis of the applicability of the assay for 
high throughput screening (HTS) was assessed using the 
maximum assay window from the data in Fig. (4). A Z’ 
value [36] of 0.64 was calculated from this data suggesting 
that this assay can be applied to HTS. 
Hsp72 FP Assay 
  Next we assessed the ability of another Hsp70 protein, 
Hsp72 to also bind to the peptide substrate Flu-ALLQ. A 
binding isotherm of the data (Fig. 5) demonstrates that 
Hsp72 also binds Flu-ALLQ in a dose-dependent manner.  
  Non-linear regression analysis yielded an apparent Kd 
value of 621.6 nM indicating that Hsp72 binds this peptide 
with ~10-fold weaker affinity than DnaK. Interestingly, us-
ing a smaller fragment of ALLQ, comparable values for 
binding to DnaK and Hsc70 were observed: 0.43 M to 
Hsc70 [31] and 0.4 M to DnaK [40]. Whether this reflects 
differences in Hsp72 and Hsc70 binding or differences in the 












Fig. (5). Differential binding of DnaK and Hsp72 to Flu-ALLQ. 
Various concentrations of DnaK and Hsp72 protein were each in-
cubated with the Flu-ALLQ peptide (50 nM) and FP values meas-
ured. 
 
  For Hsp72, a seven residue peptide (NIVRKKK, termed 
KKK) was previously identified as a Hsp70 binder [14, 17] 
and shown to compete for RCMLA binding to Hsp72 [29]. 
KKK was labeled with fluorescein and also used to measure 









Fig. (6). Binding isotherms for Hsp72 binding to unfolded poly-
peptide and synthetic peptide substrates. 
Various concentrations of Hsp72 protein were incubated with the 
Flu-KKK (20 nM) and Flu-RCMLA (1.67 g/ml) and FP values 
measured. 
 
  Binding isotherms for Hsp72 binding to Flu-KKK and 
with Flu-RCMLA as a control (Fig. 6) yield apparent Kd 
values of 13.7 M and 1.97 M respectively. An IC50 value 
for KKK binding to Hsc70 of 2.8 M has been reported pre-
viously [14]. These differences in binding for the KKK pep-
tide may reflect different selectivity’s of Hsp72 and Hsc70 
or may suggest that fluorescein labeling of this minimal 
binding sequence of seven residues may have steric effects 
on binding. The low affinity of the “charged” Hsp70 binder 
makes it a poor tracer to monitor binding and challenging to 
use in developing an assay to identify chemical probes.  
  Another set of peptides have been identified as Hsp70 
binders. Peptides derived from the MHC class I antigens 94    Current Chemical Genomics, 2008, Volume 2  Ricci and Williams 
have been shown to bind to Hsc70 and also have immuno-
suppressive properties [25,26]. We tested one of these pep-
tides from HLA-B2702 (residues 75-84; RENLRIALRY; 
Table 1) in an FP assay. This 10-mer peptide was labeled on 
the N-terminus with fluorescein (termed Flu-HLA) and used 












Fig. (7). Binding isotherm for a MHC class I-derived peptide 
sequence to Hsp72. 
Various concentrations of Hsp72 protein were incubated with the 
Flu-HLA peptide (20 nM) and FP values measured. 
 
  Non-linear regression analysis of the data in Fig. (7) 
yielded an apparent Kd value of 0.37 M for Flu-HLA bind-
ing to Hsp72. Using a biotinylated version of this peptide as 
tracer in an ELISA type competition binding assay, Woo and 
coworkers measured an IC50 value of 7 M for binding of 
this peptide to Hsc70 [26]. These differences in binding may 
reflect differences in assay format or that the HLA peptide 
has higher affinity for Hsp72 versus Hsc70.  
CONCLUSIONS 
  Our initial goal in these studies was to test the feasibility 
in developing a robust assay format that would be generally 
applicable to all members of the Hsp70 chaperone family. 
We have shown that fluorescence polarization proves to be 
an effective format for assessing both unfolded polypeptide 
and peptide substrate binding to a range of Hsp70 proteins 
including the mammalian inducible form Hsp72 and bacte-
rial DnaK. A summary of the binding data is shown in Table 
2. 
Table 2.  Summary of Substrate Binding to Hsp70 Proteins  
Hsp70 Protein  Hsp72  Dnak 
 Kd  (M) 
Substrate    
Flu-RCMLA 1.53  2.0 
Flu-ALLQ 0.62  0.064 
Flu-KKK 13.7  ND 
Flu-HLA 0.37  ND 
ND = not determined. 
  One question we wanted to address was whether we 
would be able to use a single general substrate for all Hsp70 
proteins or would individual substrates be required for each 
chaperone. We found that a 21-mer peptide Flu-ALLQ 
bound with high affinity to DnaK and as a tracer, inhibition 
by another DnaK binding peptide, LLL could be measured. 
However, binding of this peptide to Hsp72 was ~10-fold 
weaker suggesting it may not be useful as a general substrate 
even though a smaller fragment of this peptide has shown 
comparable binding to DnaK and Hsp70 [31]. Here we show 
that a 10-mer peptide derived from HLA binds well to Hsp72 
compared to other peptides tested and should serve as a 
tracer for an Hsp72 binding assay. In conclusion, we have 
identified fluorescein tagged synthetic peptide substrates 
based on the targeting sequence of the precursor of mito-
chondrial aspartate aminotransferase and on a HLA Class I 
heavy chain sequence that gave high affinity binding for 
DnaK and Hsp72 respectively. We anticipate that these FP 
assays for Hsp70 proteins will be implemented in an HTS 
format for the discovery of both selective and pan-Hsp70 
chemical probes. It will be interesting to test if screens of 
Hsp72 and DnaK yield similar or diverse hits. 
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